APO Research
Talk to an analyst

APO RESEARCH · REPORT

mRNA Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global mRNA Drug Market Analysis and Forecast 2026-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchmRNA Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal mRNA Drug Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal mRNA Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal mRNA Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal mRNA Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global mRNA Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for mRNA Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for mRNA Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for mRNA Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for mRNA Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of mRNA Drug include Janssen, Sri Lankan Microorganisms, Pfizer, Fosun Pharma, AstraZeneca, Zydus Cadila, Moderna, CureVAC and BioNtech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for mRNA Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of mRNA Drug, also provides the sales of main regions and countries. Of the upcoming market potential for mRNA Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the mRNA Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global mRNA Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for mRNA Drug sales, projected growth trends, production technology, application and end-user industry.

mRNA Drug Segment by Company

Janssen

Sri Lankan Microorganisms

Pfizer

Fosun Pharma

AstraZeneca

Zydus Cadila

Moderna

CureVAC

BioNtech

mRNA Drug Segment by Type

Therapeutic Vaccine

Therapeutic Drugs

Preventive Vaccines

mRNA Drug Segment by Application

Hospital

Clinic

mRNA Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of mRNA Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of mRNA Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of mRNA Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global mRNA Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Therapeutic Vaccine Major Manufacturers Table 3. Therapeutic Drugs Major Manufacturers Table 4. Preventive Vaccines Major Manufacturers Table 5. Global mRNA Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. mRNA Drug Industry Trends Table 9. mRNA Drug Industry Drivers Table 10. mRNA Drug Industry Opportunities and Challenges Table 11. mRNA Drug Industry Restraints Table 12. Global mRNA Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global mRNA Drug Revenue by Region (2021-2026) & (US$ Million) Table 14. Global mRNA Drug Revenue by Region (2027-2032) & (US$ Million) Table 15. Global mRNA Drug Revenue Market Share by Region (2021-2026) Table 16. Global mRNA Drug Revenue Market Share by Region (2027-2032) Table 17. Global mRNA Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global mRNA Drug Sales by Region (2021-2026) & (k units) Table 19. Global mRNA Drug Sales by Region (2027-2032) & (k units) Table 20. Global mRNA Drug Sales Market Share by Region (2021-2026) Table 21. Global mRNA Drug Sales Market Share by Region (2027-2032) Table 22. Global mRNA Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global mRNA Drug Revenue Market Share by Manufacturers (2021-2026) Table 24. Global mRNA Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global mRNA Drug Sales Market Share by Manufacturers (2021-2026) Table 26. Global mRNA Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global mRNA Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global mRNA Drug Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global mRNA Drug Manufacturers, Product Type & Application Table 30. Global mRNA Drug Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global mRNA Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global mRNA Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global mRNA Drug Revenue by Type (2021-2026) & (US$ Million) Table 35. Global mRNA Drug Revenue by Type (2027-2032) & (US$ Million) Table 36. Global mRNA Drug Revenue Market Share by Type (2021-2026) Table 37. Global mRNA Drug Revenue Market Share by Type (2027-2032) Table 38. Global mRNA Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global mRNA Drug Sales by Type (2021-2026) & (k units) Table 40. Global mRNA Drug Sales by Type (2027-2032) & (k units) Table 41. Global mRNA Drug Sales Market Share by Type (2021-2026) Table 42. Global mRNA Drug Sales Market Share by Type (2027-2032) Table 43. Global mRNA Drug Price by Type (2021-2026) & (US$/unit) Table 44. Global mRNA Drug Price by Type (2027-2032) & (US$/unit) Table 45. Global mRNA Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global mRNA Drug Revenue by Application (2021-2026) & (US$ Million) Table 47. Global mRNA Drug Revenue by Application (2027-2032) & (US$ Million) Table 48. Global mRNA Drug Revenue Market Share by Application (2021-2026) Table 49. Global mRNA Drug Revenue Market Share by Application (2027-2032) Table 50. Global mRNA Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global mRNA Drug Sales by Application (2021-2026) & (k units) Table 52. Global mRNA Drug Sales by Application (2027-2032) & (k units) Table 53. Global mRNA Drug Sales Market Share by Application (2021-2026) Table 54. Global mRNA Drug Sales Market Share by Application (2027-2032) Table 55. Global mRNA Drug Price by Application (2021-2026) & (US$/unit) Table 56. Global mRNA Drug Price by Application (2027-2032) & (US$/unit) Table 57. Janssen Company Information Table 58. Janssen Business Overview Table 59. Janssen mRNA Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Janssen mRNA Drug Product Portfolio Table 61. Janssen Recent Development Table 62. Sri Lankan Microorganisms Company Information Table 63. Sri Lankan Microorganisms Business Overview Table 64. Sri Lankan Microorganisms mRNA Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Sri Lankan Microorganisms mRNA Drug Product Portfolio Table 66. Sri Lankan Microorganisms Recent Development Table 67. Pfizer Company Information Table 68. Pfizer Business Overview Table 69. Pfizer mRNA Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Pfizer mRNA Drug Product Portfolio Table 71. Pfizer Recent Development Table 72. Fosun Pharma Company Information Table 73. Fosun Pharma Business Overview Table 74. Fosun Pharma mRNA Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Fosun Pharma mRNA Drug Product Portfolio Table 76. Fosun Pharma Recent Development Table 77. AstraZeneca Company Information Table 78. AstraZeneca Business Overview Table 79. AstraZeneca mRNA Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. AstraZeneca mRNA Drug Product Portfolio Table 81. AstraZeneca Recent Development Table 82. Zydus Cadila Company Information Table 83. Zydus Cadila Business Overview Table 84. Zydus Cadila mRNA Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Zydus Cadila mRNA Drug Product Portfolio Table 86. Zydus Cadila Recent Development Table 87. Moderna Company Information Table 88. Moderna Business Overview Table 89. Moderna mRNA Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Moderna mRNA Drug Product Portfolio Table 91. Moderna Recent Development Table 92. CureVAC Company Information Table 93. CureVAC Business Overview Table 94. CureVAC mRNA Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. CureVAC mRNA Drug Product Portfolio Table 96. CureVAC Recent Development Table 97. BioNtech Company Information Table 98. BioNtech Business Overview Table 99. BioNtech mRNA Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. BioNtech mRNA Drug Product Portfolio Table 101. BioNtech Recent Development Table 102. North America mRNA Drug Revenue by Type (2021-2026) & (US$ Million) Table 103. North America mRNA Drug Revenue by Type (2027-2032) & (US$ Million) Table 104. North America mRNA Drug Sales by Type (2021-2026) & (k units) Table 105. North America mRNA Drug Sales by Type (2027-2032) & (k units) Table 106. North America mRNA Drug Sales Price by Type (2021-2026) & (US$/unit) Table 107. North America mRNA Drug Sales Price by Type (2027-2032) & (US$/unit) Table 108. North America mRNA Drug Revenue by Application (2021-2026) & (US$ Million) Table 109. North America mRNA Drug Revenue by Application (2027-2032) & (US$ Million) Table 110. North America mRNA Drug Sales by Application (2021-2026) & (k units) Table 111. North America mRNA Drug Sales by Application (2027-2032) & (k units) Table 112. North America mRNA Drug Sales Price by Application (2021-2026) & (US$/unit) Table 113. North America mRNA Drug Sales Price by Application (2027-2032) & (US$/unit) Table 114. North America mRNA Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America mRNA Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. North America mRNA Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. North America mRNA Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 118. North America mRNA Drug Sales by Country (2021-2026) & (k units) Table 119. North America mRNA Drug Sales by Country (2027-2032) & (k units) Table 120. North America mRNA Drug Sales Price by Country (2021-2026) & (US$/unit) Table 121. North America mRNA Drug Sales Price by Country (2027-2032) & (US$/unit) Table 122. United States mRNA Drug Revenue (2021-2032) & (US$ Million) Table 123. Canada mRNA Drug Revenue (2021-2032) & (US$ Million) Table 124. Mexico mRNA Drug Revenue (2021-2032) & (US$ Million) Table 125. Europe mRNA Drug Revenue by Type (2021-2026) & (US$ Million) Table 126. Europe mRNA Drug Revenue by Type (2027-2032) & (US$ Million) Table 127. Europe mRNA Drug Sales by Type (2021-2026) & (k units) Table 128. Europe mRNA Drug Sales by Type (2027-2032) & (k units) Table 129. Europe mRNA Drug Sales Price by Type (2021-2026) & (US$/unit) Table 130. Europe mRNA Drug Sales Price by Type (2027-2032) & (US$/unit) Table 131. Europe mRNA Drug Revenue by Application (2021-2026) & (US$ Million) Table 132. Europe mRNA Drug Revenue by Application (2027-2032) & (US$ Million) Table 133. Europe mRNA Drug Sales by Application (2021-2026) & (k units) Table 134. Europe mRNA Drug Sales by Application (2027-2032) & (k units) Table 135. Europe mRNA Drug Sales Price by Application (2021-2026) & (US$/unit) Table 136. Europe mRNA Drug Sales Price by Application (2027-2032) & (US$/unit) Table 137. Europe mRNA Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe mRNA Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 139. Europe mRNA Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 140. Europe mRNA Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 141. Europe mRNA Drug Sales by Country (2021-2026) & (k units) Table 142. Europe mRNA Drug Sales by Country (2027-2032) & (k units) Table 143. Europe mRNA Drug Sales Price by Country (2021-2026) & (US$/unit) Table 144. Europe mRNA Drug Sales Price by Country (2027-2032) & (US$/unit) Table 145. Germany mRNA Drug Revenue (2021-2032) & (US$ Million) Table 146. France mRNA Drug Revenue (2021-2032) & (US$ Million) Table 147. U.K. mRNA Drug Revenue (2021-2032) & (US$ Million) Table 148. Italy mRNA Drug Revenue (2021-2032) & (US$ Million) Table 149. Russia mRNA Drug Revenue (2021-2032) & (US$ Million) Table 150. Spain mRNA Drug Revenue (2021-2032) & (US$ Million) Table 151. Netherlands mRNA Drug Revenue (2021-2032) & (US$ Million) Table 152. Switzerland mRNA Drug Revenue (2021-2032) & (US$ Million) Table 153. Sweden mRNA Drug Revenue (2021-2032) & (US$ Million) Table 154. Poland mRNA Drug Revenue (2021-2032) & (US$ Million) Table 155. China mRNA Drug Revenue by Type (2021-2026) & (US$ Million) Table 156. China mRNA Drug Revenue by Type (2027-2032) & (US$ Million) Table 157. China mRNA Drug Sales by Type (2021-2026) & (k units) Table 158. China mRNA Drug Sales by Type (2027-2032) & (k units) Table 159. China mRNA Drug Sales Price by Type (2021-2026) & (US$/unit) Table 160. China mRNA Drug Sales Price by Type (2027-2032) & (US$/unit) Table 161. China mRNA Drug Revenue by Application (2021-2026) & (US$ Million) Table 162. China mRNA Drug Revenue by Application (2027-2032) & (US$ Million) Table 163. China mRNA Drug Sales by Application (2021-2026) & (k units) Table 164. China mRNA Drug Sales by Application (2027-2032) & (k units) Table 165. China mRNA Drug Sales Price by Application (2021-2026) & (US$/unit) Table 166. China mRNA Drug Sales Price by Application (2027-2032) & (US$/unit) Table 167. Asia mRNA Drug Revenue by Type (2021-2026) & (US$ Million) Table 168. Asia mRNA Drug Revenue by Type (2027-2032) & (US$ Million) Table 169. Asia mRNA Drug Sales by Type (2021-2026) & (k units) Table 170. Asia mRNA Drug Sales by Type (2027-2032) & (k units) Table 171. Asia mRNA Drug Sales Price by Type (2021-2026) & (US$/unit) Table 172. Asia mRNA Drug Sales Price by Type (2027-2032) & (US$/unit) Table 173. Asia mRNA Drug Revenue by Application (2021-2026) & (US$ Million) Table 174. Asia mRNA Drug Revenue by Application (2027-2032) & (US$ Million) Table 175. Asia mRNA Drug Sales by Application (2021-2026) & (k units) Table 176. Asia mRNA Drug Sales by Application (2027-2032) & (k units) Table 177. Asia mRNA Drug Sales Price by Application (2021-2026) & (US$/unit) Table 178. Asia mRNA Drug Sales Price by Application (2027-2032) & (US$/unit) Table 179. Asia mRNA Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Asia mRNA Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. Asia mRNA Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. Asia mRNA Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 183. Asia mRNA Drug Sales by Country (2021-2026) & (k units) Table 184. Asia mRNA Drug Sales by Country (2027-2032) & (k units) Table 185. Asia mRNA Drug Sales Price by Country (2021-2026) & (US$/unit) Table 186. Asia mRNA Drug Sales Price by Country (2027-2032) & (US$/unit) Table 187. Japan mRNA Drug Revenue (2021-2032) & (US$ Million) Table 188. South Korea mRNA Drug Revenue (2021-2032) & (US$ Million) Table 189. India mRNA Drug Revenue (2021-2032) & (US$ Million) Table 190. Australia mRNA Drug Revenue (2021-2032) & (US$ Million) Table 191. Taiwan mRNA Drug Revenue (2021-2032) & (US$ Million) Table 192. Southeast Asia mRNA Drug Revenue (2021-2032) & (US$ Million) Table 193. SAMEA mRNA Drug Revenue by Type (2021-2026) & (US$ Million) Table 194. SAMEA mRNA Drug Revenue by Type (2027-2032) & (US$ Million) Table 195. SAMEA mRNA Drug Sales by Type (2021-2026) & (k units) Table 196. SAMEA mRNA Drug Sales by Type (2027-2032) & (k units) Table 197. SAMEA mRNA Drug Sales Price by Type (2021-2026) & (US$/unit) Table 198. SAMEA mRNA Drug Sales Price by Type (2027-2032) & (US$/unit) Table 199. SAMEA mRNA Drug Revenue by Application (2021-2026) & (US$ Million) Table 200. SAMEA mRNA Drug Revenue by Application (2027-2032) & (US$ Million) Table 201. SAMEA mRNA Drug Sales by Application (2021-2026) & (k units) Table 202. SAMEA mRNA Drug Sales by Application (2027-2032) & (k units) Table 203. SAMEA mRNA Drug Sales Price by Application (2021-2026) & (US$/unit) Table 204. SAMEA mRNA Drug Sales Price by Application (2027-2032) & (US$/unit) Table 205. SAMEA mRNA Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. SAMEA mRNA Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. SAMEA mRNA Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. SAMEA mRNA Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 209. SAMEA mRNA Drug Sales by Country (2021-2026) & (k units) Table 210. SAMEA mRNA Drug Sales by Country (2027-2032) & (k units) Table 211. SAMEA mRNA Drug Sales Price by Country (2021-2026) & (US$/unit) Table 212. SAMEA mRNA Drug Sales Price by Country (2027-2032) & (US$/unit) Table 213. Brazil mRNA Drug Revenue (2021-2032) & (US$ Million) Table 214. Argentina mRNA Drug Revenue (2021-2032) & (US$ Million) Table 215. Chile mRNA Drug Revenue (2021-2032) & (US$ Million) Table 216. Colombia mRNA Drug Revenue (2021-2032) & (US$ Million) Table 217. Peru mRNA Drug Revenue (2021-2032) & (US$ Million) Table 218. Saudi Arabia mRNA Drug Revenue (2021-2032) & (US$ Million) Table 219. Israel mRNA Drug Revenue (2021-2032) & (US$ Million) Table 220. UAE mRNA Drug Revenue (2021-2032) & (US$ Million) Table 221. Turkey mRNA Drug Revenue (2021-2032) & (US$ Million) Table 222. Iran mRNA Drug Revenue (2021-2032) & (US$ Million) Table 223. Egypt mRNA Drug Revenue (2021-2032) & (US$ Million) Table 224. Key Raw Materials Table 225. Raw Materials Key Suppliers Table 226. mRNA Drug Distributors List Table 227. mRNA Drug Customers List Table 228. Research Programs/Design for This Report Table 229. Authors List of This Report Table 230. Secondary Sources Table 231. Primary Sources List of Figures Figure 1. mRNA Drug Image Figure 2. Global mRNA Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global mRNA Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Therapeutic Vaccine Image Figure 5. Therapeutic Drugs Image Figure 6. Preventive Vaccines Image Figure 7. Global mRNA Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global mRNA Drug Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Global mRNA Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global mRNA Drug Revenue (2021-2032) & (US$ Million) Figure 13. Global mRNA Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global mRNA Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global mRNA Drug Revenue Market Share by Region (2021-2032) Figure 16. Global mRNA Drug Sales (2021-2032) & (k units) Figure 17. Global mRNA Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global mRNA Drug Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico mRNA Drug Sales YoY (2021-2032) & (k units) Figure 20. Europe mRNA Drug Sales YoY (2021-2032) & (k units) Figure 21. China mRNA Drug Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) mRNA Drug Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa mRNA Drug Sales YoY (2021-2032) & (k units) Figure 24. Global mRNA Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global mRNA Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global mRNA Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global mRNA Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global mRNA Drug Revenue Market Share by Type (2021-2032) Figure 30. Global mRNA Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global mRNA Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global mRNA Drug Sales Market Share by Type (2021-2032) Figure 33. Global mRNA Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global mRNA Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global mRNA Drug Revenue Market Share by Application (2021-2032) Figure 36. Global mRNA Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global mRNA Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global mRNA Drug Sales Market Share by Application (2021-2032) Figure 39. North America mRNA Drug Revenue Share by Type (2021-2032) Figure 40. North America mRNA Drug Sales Share by Type (2021-2032) Figure 41. North America mRNA Drug Revenue Share by Application (2021-2032) Figure 42. North America mRNA Drug Sales Share by Application (2021-2032) Figure 43. North America mRNA Drug Revenue Share by Country (2021-2032) Figure 44. North America mRNA Drug Sales Share by Country (2021-2032) Figure 45. Europe mRNA Drug Revenue Share by Type (2021-2032) Figure 46. Europe mRNA Drug Sales Share by Type (2021-2032) Figure 47. Europe mRNA Drug Revenue Share by Application (2021-2032) Figure 48. Europe mRNA Drug Sales Share by Application (2021-2032) Figure 49. Europe mRNA Drug Revenue Share by Country (2021-2032) Figure 50. Europe mRNA Drug Sales Share by Country (2021-2032) Figure 51. China mRNA Drug Revenue Share by Type (2021-2032) Figure 52. China mRNA Drug Sales Share by Type (2021-2032) Figure 53. China mRNA Drug Revenue Share by Application (2021-2032) Figure 54. China mRNA Drug Sales Share by Application (2021-2032) Figure 55. Asia mRNA Drug Revenue Share by Type (2021-2032) Figure 56. Asia mRNA Drug Sales Share by Type (2021-2032) Figure 57. Asia mRNA Drug Revenue Share by Application (2021-2032) Figure 58. Asia mRNA Drug Sales Share by Application (2021-2032) Figure 59. Asia mRNA Drug Revenue Share by Country (2021-2032) Figure 60. Asia mRNA Drug Sales Share by Country (2021-2032) Figure 61. SAMEA mRNA Drug Revenue Share by Type (2021-2032) Figure 62. SAMEA mRNA Drug Sales Share by Type (2021-2032) Figure 63. SAMEA mRNA Drug Revenue Share by Application (2021-2032) Figure 64. SAMEA mRNA Drug Sales Share by Application (2021-2032) Figure 65. SAMEA mRNA Drug Revenue Share by Country (2021-2032) Figure 66. SAMEA mRNA Drug Sales Share by Country (2021-2032) Figure 67. mRNA Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. mRNA Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Therapeutic Vaccine
  • Therapeutic Drugs
  • Preventive Vaccines
Applications
  • Hospital
  • Clinic
Companies covered
  • Janssen
  • Sri Lankan Microorganisms
  • Pfizer
  • Fosun Pharma
  • AstraZeneca
  • Zydus Cadila
  • Moderna
  • CureVAC
  • BioNtech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 mRNA Drug Market by Type
  3. 1.2.1 Global mRNA Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Therapeutic Vaccine
  5. 1.2.3 Therapeutic Drugs
  6. 1.2.4 Preventive Vaccines
  7. 1.3 mRNA Drug Market by Application
  8. 1.3.1 Global mRNA Drug Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 mRNA Drug Market Dynamics
  1. 2.1 mRNA Drug Industry Trends
  2. 2.2 mRNA Drug Industry Drivers
  3. 2.3 mRNA Drug Industry Opportunities and Challenges
  4. 2.4 mRNA Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global mRNA Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global mRNA Drug Revenue by Region
  3. 3.2.1 Global mRNA Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global mRNA Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global mRNA Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global mRNA Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global mRNA Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global mRNA Drug Sales by Region
  9. 3.4.1 Global mRNA Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global mRNA Drug Sales by Region (2021-2026)
  11. 3.4.3 Global mRNA Drug Sales by Region (2027-2032)
  12. 3.4.4 Global mRNA Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global mRNA Drug Revenue by Manufacturers
  2. 4.1.1 Global mRNA Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global mRNA Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global mRNA Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global mRNA Drug Sales by Manufacturers
  6. 4.2.1 Global mRNA Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global mRNA Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global mRNA Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global mRNA Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global mRNA Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global mRNA Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global mRNA Drug Manufacturers, Product Type & Application
  13. 4.7 Global mRNA Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global mRNA Drug Market CR5 and HHI
  16. 4.8.2 2025 mRNA Drug Tier 1, Tier 2, and Tier 3
5 mRNA Drug Market by Type
  1. 5.1 Global mRNA Drug Revenue by Type
  2. 5.1.1 Global mRNA Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global mRNA Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global mRNA Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global mRNA Drug Sales by Type
  6. 5.2.1 Global mRNA Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global mRNA Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global mRNA Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global mRNA Drug Price by Type
6 mRNA Drug Market by Application
  1. 6.1 Global mRNA Drug Revenue by Application
  2. 6.1.1 Global mRNA Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global mRNA Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global mRNA Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global mRNA Drug Sales by Application
  6. 6.2.1 Global mRNA Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global mRNA Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global mRNA Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global mRNA Drug Price by Application
7 Company Profiles
  1. 7.1 Janssen
  2. 7.1.1 Janssen Company Information
  3. 7.1.2 Janssen Business Overview
  4. 7.1.3 Janssen mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Janssen mRNA Drug Product Portfolio
  6. 7.1.5 Janssen Recent Developments
  7. 7.2 Sri Lankan Microorganisms
  8. 7.2.1 Sri Lankan Microorganisms Company Information
  9. 7.2.2 Sri Lankan Microorganisms Business Overview
  10. 7.2.3 Sri Lankan Microorganisms mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sri Lankan Microorganisms mRNA Drug Product Portfolio
  12. 7.2.5 Sri Lankan Microorganisms Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer mRNA Drug Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 Fosun Pharma
  20. 7.4.1 Fosun Pharma Company Information
  21. 7.4.2 Fosun Pharma Business Overview
  22. 7.4.3 Fosun Pharma mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Fosun Pharma mRNA Drug Product Portfolio
  24. 7.4.5 Fosun Pharma Recent Developments
  25. 7.5 AstraZeneca
  26. 7.5.1 AstraZeneca Company Information
  27. 7.5.2 AstraZeneca Business Overview
  28. 7.5.3 AstraZeneca mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AstraZeneca mRNA Drug Product Portfolio
  30. 7.5.5 AstraZeneca Recent Developments
  31. 7.6 Zydus Cadila
  32. 7.6.1 Zydus Cadila Company Information
  33. 7.6.2 Zydus Cadila Business Overview
  34. 7.6.3 Zydus Cadila mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Zydus Cadila mRNA Drug Product Portfolio
  36. 7.6.5 Zydus Cadila Recent Developments
  37. 7.7 Moderna
  38. 7.7.1 Moderna Company Information
  39. 7.7.2 Moderna Business Overview
  40. 7.7.3 Moderna mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Moderna mRNA Drug Product Portfolio
  42. 7.7.5 Moderna Recent Developments
  43. 7.8 CureVAC
  44. 7.8.1 CureVAC Company Information
  45. 7.8.2 CureVAC Business Overview
  46. 7.8.3 CureVAC mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 CureVAC mRNA Drug Product Portfolio
  48. 7.8.5 CureVAC Recent Developments
  49. 7.9 BioNtech
  50. 7.9.1 BioNtech Company Information
  51. 7.9.2 BioNtech Business Overview
  52. 7.9.3 BioNtech mRNA Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 BioNtech mRNA Drug Product Portfolio
  54. 7.9.5 BioNtech Recent Developments
8 North America
  1. 8.1 North America mRNA Drug Market Size by Type
  2. 8.1.1 North America mRNA Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America mRNA Drug Sales by Type (2021-2032)
  4. 8.1.3 North America mRNA Drug Price by Type (2021-2032)
  5. 8.2 North America mRNA Drug Market Size by Application
  6. 8.2.1 North America mRNA Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America mRNA Drug Sales by Application (2021-2032)
  8. 8.2.3 North America mRNA Drug Price by Application (2021-2032)
  9. 8.3 North America mRNA Drug Market Size by Country
  10. 8.3.1 North America mRNA Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America mRNA Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America mRNA Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe mRNA Drug Market Size by Type
  2. 9.1.1 Europe mRNA Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe mRNA Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe mRNA Drug Price by Type (2021-2032)
  5. 9.2 Europe mRNA Drug Market Size by Application
  6. 9.2.1 Europe mRNA Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe mRNA Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe mRNA Drug Price by Application (2021-2032)
  9. 9.3 Europe mRNA Drug Market Size by Country
  10. 9.3.1 Europe mRNA Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe mRNA Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe mRNA Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China mRNA Drug Market Size by Type
  2. 10.1.1 China mRNA Drug Revenue by Type (2021-2032)
  3. 10.1.2 China mRNA Drug Sales by Type (2021-2032)
  4. 10.1.3 China mRNA Drug Price by Type (2021-2032)
  5. 10.2 China mRNA Drug Market Size by Application
  6. 10.2.1 China mRNA Drug Revenue by Application (2021-2032)
  7. 10.2.2 China mRNA Drug Sales by Application (2021-2032)
  8. 10.2.3 China mRNA Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia mRNA Drug Market Size by Type
  2. 11.1.1 Asia mRNA Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia mRNA Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia mRNA Drug Price by Type (2021-2032)
  5. 11.2 Asia mRNA Drug Market Size by Application
  6. 11.2.1 Asia mRNA Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia mRNA Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia mRNA Drug Price by Application (2021-2032)
  9. 11.3 Asia mRNA Drug Market Size by Country
  10. 11.3.1 Asia mRNA Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia mRNA Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia mRNA Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA mRNA Drug Market Size by Type
  2. 12.1.1 SAMEA mRNA Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA mRNA Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA mRNA Drug Price by Type (2021-2032)
  5. 12.2 SAMEA mRNA Drug Market Size by Application
  6. 12.2.1 SAMEA mRNA Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA mRNA Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA mRNA Drug Price by Application (2021-2032)
  9. 12.3 SAMEA mRNA Drug Market Size by Country
  10. 12.3.1 SAMEA mRNA Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA mRNA Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA mRNA Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 mRNA Drug Value Chain Analysis
  2. 13.1.1 mRNA Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 mRNA Drug Production Mode & Process
  6. 13.2 mRNA Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 mRNA Drug Distributors
  9. 13.2.3 mRNA Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst